Macrophage EP4 Deficiency Increases Apoptosis and Suppresses Early Atherosclerosis

Overview

Journal Cell Metab

Publisher Cell Press

Specialties Cell Biology
Endocrinology

Date 2008 Dec 2

PMID 19041765

Citations 58

Authors

Vladimir R Babaev

Joshua D Chew

Lei Ding

Sarah Davis

Matthew D Breyer

Richard M Breyer

John A Oates

Sergio Fazio

MacRae F Linton

Affiliations

Soon will be listed here.

Abstract

Prostaglandin (PG) E(2), a major product of activated macrophages, has been implicated in atherosclerosis and plaque rupture. The PGE(2) receptors, EP2 and EP4, are expressed in atherosclerotic lesions and are known to inhibit apoptosis in cancer cells. To examine the roles of macrophage EP4 and EP2 in apoptosis and early atherosclerosis, fetal liver cell transplantation was used to generate LDLR(-/-) mice chimeric for EP2(-/-) or EP4(-/-) hematopoietic cells. After 8 weeks on a Western diet, EP4(-/-) --> LDLR(-/-) mice, but not EP2(-/-) --> LDLR(-/-) mice, had significantly reduced aortic atherosclerosis with increased apoptotic cells in the lesions. EP4(-/-) peritoneal macrophages had increased sensitivity to proapoptotic stimuli, including palmitic acid and free cholesterol loading, which was accompanied by suppression of activity of p-Akt, p-Bad, and NF-kappaB-regulated genes. Thus, EP4 deficiency inhibits the PI3K/Akt and NF-kappaB pathways compromising macrophage survival and suppressing early atherosclerosis, identifying macrophage EP4-signaling pathways as molecular targets for modulating the development of atherosclerosis.

Citing Articles

Peritoneal fibrosis: from pathophysiological mechanism to medicine.

Kang Y, Liu Y, Fu P, Ma L Front Physiol. 2024; 15:1438952.

PMID: 39301425 PMC: 11411570. DOI: 10.3389/fphys.2024.1438952.

Disruption of the PGE synthesis / response pathway restrains atherogenesis in programmed cell death-1 (Pd-1) deficient hyperlipidemic mice.

Ricciotti E, Tang S, Mrcela A, Das U, Lordan R, Joshi R bioRxiv. 2024; .

PMID: 39005376 PMC: 11244953. DOI: 10.1101/2024.07.02.601762.

Prostanoids in Cardiac and Vascular Remodeling.

Ricciotti E, Haines P, Chai W, FitzGerald G Arterioscler Thromb Vasc Biol. 2024; 44(3):558-583.

PMID: 38269585 PMC: 10922399. DOI: 10.1161/ATVBAHA.123.320045.

Single hormone or synthetic agonist induces G/G coupling selectivity of EP receptors via distinct binding modes and propagating paths.

Huang S, Xiong M, Liu L, Mu J, Wang M, Jia Y Proc Natl Acad Sci U S A. 2023; 120(30):e2216329120.

PMID: 37478163 PMC: 10372679. DOI: 10.1073/pnas.2216329120.

Application of silver nanoparticles for improving motor recovery after spinal cord injury via reduction of pro-inflammatory M1 macrophages.

Lin J, Chen P, Tan Z, Sun Y, Tam W, Ao D Heliyon. 2023; 9(5):e15689.

PMID: 37234658 PMC: 10205515. DOI: 10.1016/j.heliyon.2023.e15689.

References

Babaev V, Fazio S, Gleaves L, Carter K, Semenkovich C, Linton M . Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest. 1999; 103(12):1697-705. PMC: 408384. DOI: 10.1172/JCI6117. View

Madrid L, Wang C, Guttridge D, Schottelius A, Baldwin Jr A, Mayo M . Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol. 2000; 20(5):1626-38. PMC: 85346. DOI: 10.1128/MCB.20.5.1626-1638.2000. View

Liu J, Thewke D, Ru Su Y, Linton M, Fazio S, Sinensky M . Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol. 2004; 25(1):174-9. PMC: 2649706. DOI: 10.1161/01.ATV.0000148548.47755.22. View

Vassiliou E, Sharma V, Jing H, Sheibanie F, Ganea D . Prostaglandin E2 promotes the survival of bone marrow-derived dendritic cells. J Immunol. 2004; 173(11):6955-64. DOI: 10.4049/jimmunol.173.11.6955. View

Chang J, Sukhova G, Libby P, Schvartz E, Lichtenstein A, Field S . Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis. Proc Natl Acad Sci U S A. 2007; 104(19):8077-82. PMC: 1864909. DOI: 10.1073/pnas.0702663104. View

Kockx M . Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol. 1998; 18(10):1519-22. DOI: 10.1161/01.atv.18.10.1519. View

Tabas I . Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol. 2005; 25(11):2255-64. DOI: 10.1161/01.ATV.0000184783.04864.9f. View

Nguyen M, Camenisch T, Snouwaert J, Hicks E, Coffman T, Anderson P . The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature. 1997; 390(6655):78-81. DOI: 10.1038/36342. View

Cheng Y, Austin S, Rocca B, Koller B, Coffman T, Grosser T . Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002; 296(5567):539-41. DOI: 10.1126/science.1068711. View

10.

Solomon S, McMurray J, Pfeffer M, Wittes J, Fowler R, Finn P . Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005; 352(11):1071-80. DOI: 10.1056/NEJMoa050405. View

11.

Lizcano J, Morrice N, Cohen P . Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J. 2000; 349(Pt 2):547-57. PMC: 1221178. DOI: 10.1042/0264-6021:3490547. View

12.

Gomez-Hernandez A, Martin-Ventura J, Sanchez-Galan E, Vidal C, Ortego M, Blanco-Colio L . Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB. Atherosclerosis. 2005; 187(1):139-49. DOI: 10.1016/j.atherosclerosis.2005.08.035. View

13.

Fazio S, Babaev V, Murray A, Hasty A, Carter K, Gleaves L . Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci U S A. 1997; 94(9):4647-52. PMC: 20778. DOI: 10.1073/pnas.94.9.4647. View

14.

Wei M, Zong W, Cheng E, LINDSTEN T, Panoutsakopoulou V, Ross A . Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001; 292(5517):727-30. PMC: 3049805. DOI: 10.1126/science.1059108. View

15.

Nhan T, Liles W, Schwartz S . Role of caspases in death and survival of the plaque macrophage. Arterioscler Thromb Vasc Biol. 2005; 25(5):895-903. DOI: 10.1161/01.ATV.0000159519.07181.33. View

16.

Breyer R, Bagdassarian C, Myers S, Breyer M . Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol. 2001; 41:661-90. DOI: 10.1146/annurev.pharmtox.41.1.661. View

17.

Brunet A, Bonni A, Zigmond M, Lin M, Juo P, Hu L . Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999; 96(6):857-68. DOI: 10.1016/s0092-8674(00)80595-4. View

18.

Linton M, Fazio S . Cyclooxygenase products and atherosclerosis. Drug Discov Today Ther Strateg. 2009; 5(1):25-36. PMC: 2630286. DOI: 10.1016/j.ddstr.2008.05.006. View

19.

Han S, Liang C, DeVries-Seimon T, Ranalletta M, Welch C, Collins-Fletcher K . Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab. 2006; 3(4):257-66. DOI: 10.1016/j.cmet.2006.02.008. View

20.

Nataraj C, Thomas D, Tilley S, Nguyen M, Mannon R, Koller B . Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest. 2001; 108(8):1229-35. PMC: 209534. DOI: 10.1172/JCI13640. View